Kayla Bevels
Psychiatric/Mental Health · Pelham, ALNPI 1265019558
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 381 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,048 and has fallen 98.4% since, to $49 in 2025. Among psychiatric/mental health clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 381 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$920
- Otsuka America Pharmaceutical, Inc.$797
- Corium, LLC$766
- Lundbeck LLC$578
- plus $3K from 17 others
What the payments were for
- Food & beverage$8,642100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 43 | $1,537 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 53 | $1,238 |
| Alkermes, Inc. | 37 | $920 |
| Otsuka America Pharmaceutical, Inc. | 24 | $797 |
| Corium, LLC | 32 | $766 |
| Lundbeck LLC | 28 | $578 |
| Teva Pharmaceuticals USA, Inc. | 28 | $484 |
| Ironshore Pharmaceuticals Inc. | 25 | $411 |
| Neurocrine Biosciences, Inc. | 16 | $401 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $286 |
| AbbVie | 23 | $271 |
| Axsome Therapeutics, Inc. | 11 | $188 |
| Supernus Pharmaceuticals, Inc. | 13 | $169 |
| Vanda Pharmaceuticals Inc. | 6 | $118 |
| Noven Therapeutics, LLC | 5 | $102 |
| Indivior Inc. | 5 | $101 |
| Almatica Pharma LLC | 4 | $84 |
| Tris Pharma Inc | 4 | $73 |
| Neos Therapeutics, LP | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$929
- SPRAVATO$515
- LYBALVI$500
- ABILIFY MAINTENA$361
- CAPLYTA$250
- ARISTADA INITIO$232
- INGREZZA$132
- ABILIFY ASIMTUFII$125
- INVEGA SUSTENNA$122
- INVEGA TRINZA$122
How this compares
$8,642 in reported general payments places this provider in the 90th percentile of 378 psychiatric/mental health providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 14 | $193 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Pelham
- Alaina ContestabilePelham$12K
- Laura GrahamMontgomery$80K
- Yuliya SpencerBirmingham$65K
- Keri BarrBay Minette$35K
- John HayesMobile$30K
- Logan ThrasherHoover$22K
- Anthony PhillipsHelena$15K
- Ian KinzerHuntsville$15K
- Latisha AliHoover$15K
- Taylor BarrettGadsden$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.